Coverage dated October 19, 2026

Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters

Headline from Geneng News

IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics, creating a high-resolution immune dataset to advance AI-driven biomedical research and disease prediction.

Geneng News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

WFMZ Allentown
Ultima Genomics Selected for Landmark Large-Scale Immune Profiling Study with IMU Biosciences, UK Biobank and Waters Corporation (opens WFMZ Allentown)
Published Oct 19, 2026
WFMZ Allentown's feed description
IMU Biosciences and UK Biobank will generate a single-cell immune profiling AI foundational dataset from 80,000 blood samples collected from UK Biobank participants using Ultima Genomics' UG200™ Sequencing Platform and the BD Rhapsody™ Single-Cell Platform from Waters Corporation
Geneng News
Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters (opens Geneng News)
Published Oct 19, 2026
Geneng News's feed description
IMU Biosciences and UK Biobank will profile 80,000 blood samples using technologies from Waters and Ultima Genomics, creating a high-resolution immune dataset to advance AI-driven biomedical research and disease prediction.